BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Biosimilar User Fee Act III Future Needs in the Development 
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-19166-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20261117
DTEND;VALUE=DATE:20261118
SUMMARY:FDA comments close: Biosimilar User Fee Act III Future Needs in th
 e Development of Interchangeable Products Post-Workshop\; Draft Strategy 
 Document
DESCRIPTION:Notice. Federal Register 2026-19166. Docket FDA-2025-N-2787. D
 etails: https://docket-clock.pages.dev/doc/2026-19166/ Official: https://
 www.federalregister.gov/documents/2026/09/18/2026-19166/biosimilar-user-f
 ee-act-iii-future-needs-in-the-development-of-interchangeable-products
URL:https://www.federalregister.gov/documents/2026/09/18/2026-19166/biosim
 ilar-user-fee-act-iii-future-needs-in-the-development-of-interchangeable-
 products
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR